Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06096025 · ClinicalTrials.gov registry record
Short Versus Long Duration of Therapy for Streptococcus Pneumoniae Bloodstream Infections
A clinical trial of Streptococcus Pneumoniae, sponsored by Methodist Health System.
- Active
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT06096025 is a study of Streptococcus Pneumoniae that is active but no longer recruiting, run by Methodist Health System. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06096025, a study of Streptococcus Pneumoniae, is active but no longer recruiting, sponsored by Methodist Health System.
- ACTIVE NOT RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Streptococcus pneumoniae is a gram-positive (GP) bacteria responsible for common infections such as community-acquired pneumonia (CAP), as well as complicated infections such as bacteremia, infective endocarditis and meningitis. S. pneumoniae bacteremia ranks among the top 10 most common pathogens associated with bloodstream infections and correlates with high morbidity and mortality worldwide.
Conditions Studied
Interventions
- DRUG pneumoniae bacteremia therapy
Study Locations (1)
Texas
- Methodist Dallas Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-06-23 |
| Est. Completion | 2026-06-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06096025
The ClinicalTrials.gov registry entry for NCT06096025 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Methodist Health System, which has 125 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Streptococcus Pneumoniae appearing as the primary indexed condition, and to 1 intervention - of which pneumoniae bacteremia therapy is the first listed.
NCT06096025 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06096025 about?
NCT06096025 is a clinical study titled "Short Versus Long Duration of Therapy for Streptococcus Pneumoniae Bloodstream Infections". Streptococcus pneumoniae is a gram-positive (GP) bacteria responsible for common infections such as community-acquired pneumonia (CAP), as well as complicated infections such as bacteremia, infective endocarditis and meningitis. S. pneumoniae bacteremia ranks among the top 10 most common pathogens a...
What is the current status of trial NCT06096025?
This trial is currently active not recruiting. The enrollment target is 200 participants. The study started on 2023-06-23. Estimated completion is 2026-06-23.
What conditions does trial NCT06096025 study?
This clinical trial studies the following conditions: Streptococcus Pneumoniae.
What interventions are being tested in trial NCT06096025?
The interventions under investigation include: pneumoniae bacteremia therapy (DRUG).
Who is sponsoring clinical trial NCT06096025?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06096025 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Streptococcus Pneumoniae
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.